<p>Last year’s Q3 profits were dented by a Rs 46 crore ‘mark to market’ loss on foreign exchange exposure of the company. Adjusted for this exceptional item, Biocon’s profits at Rs 81 crore was 9 per cent higher in the December 2009 quarter. <br /><br />The company reported a total income of Rs 642 crore in the December 2009 quarter, up 42 per cent from last year.</p>
<p>Last year’s Q3 profits were dented by a Rs 46 crore ‘mark to market’ loss on foreign exchange exposure of the company. Adjusted for this exceptional item, Biocon’s profits at Rs 81 crore was 9 per cent higher in the December 2009 quarter. <br /><br />The company reported a total income of Rs 642 crore in the December 2009 quarter, up 42 per cent from last year.</p>
